DK0905254T3 - Fremgangsmåde til fremstilling af en lavemolekylær - Google Patents

Fremgangsmåde til fremstilling af en lavemolekylær

Info

Publication number
DK0905254T3
DK0905254T3 DK98117722T DK98117722T DK0905254T3 DK 0905254 T3 DK0905254 T3 DK 0905254T3 DK 98117722 T DK98117722 T DK 98117722T DK 98117722 T DK98117722 T DK 98117722T DK 0905254 T3 DK0905254 T3 DK 0905254T3
Authority
DK
Denmark
Prior art keywords
preparation
molecular weight
low molecular
low
weight
Prior art date
Application number
DK98117722T
Other languages
Danish (da)
English (en)
Inventor
Thomas Prof Dr Kissel
Dagmar Dr Fischer
Hans-Peter Dr Elsaesser
Thorsten Bieber
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK0905254T3 publication Critical patent/DK0905254T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Lubricants (AREA)
DK98117722T 1997-09-30 1998-09-18 Fremgangsmåde til fremstilling af en lavemolekylær DK0905254T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19743135A DE19743135A1 (de) 1997-09-30 1997-09-30 Biologisch verträgliche niedermolekular Polyethylenimine

Publications (1)

Publication Number Publication Date
DK0905254T3 true DK0905254T3 (da) 2006-08-21

Family

ID=7844109

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98117722T DK0905254T3 (da) 1997-09-30 1998-09-18 Fremgangsmåde til fremstilling af en lavemolekylær

Country Status (19)

Country Link
US (2) US8003734B2 (fr)
EP (1) EP0905254B1 (fr)
JP (1) JP4399042B2 (fr)
KR (1) KR19990030290A (fr)
AR (1) AR015726A1 (fr)
AT (1) ATE324397T1 (fr)
AU (1) AU758239B2 (fr)
BR (1) BR9803982A (fr)
CA (1) CA2249058A1 (fr)
CY (1) CY1105109T1 (fr)
CZ (1) CZ310598A3 (fr)
DE (2) DE19743135A1 (fr)
DK (1) DK0905254T3 (fr)
ES (1) ES2264180T3 (fr)
HU (1) HUP9802157A3 (fr)
ID (1) ID20973A (fr)
PL (1) PL328910A1 (fr)
PT (1) PT905254E (fr)
TR (1) TR199801933A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19956029A1 (de) * 1999-11-22 2001-05-23 Aventis Pharma Gmbh Trägersysteme enthaltend Hüllsubstanzen mit enzymatisch abspaltbaren Seitengruppen
DE19960206A1 (de) * 1999-12-14 2001-07-19 Frank Czubayko Komplexierung von RNS mit Polyethyleniminen zur deren Stabilisierung und zellulären Einschleusung
ES2263589T3 (es) * 2000-02-18 2006-12-16 Centelion Procedimiento para aplicar polialquileniminas funcionalizadas, composiciones que las contienen y sus aplicaciones.
FR2805271B1 (fr) * 2000-02-18 2002-04-26 Aventis Pharma Sa Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations
US6696038B1 (en) * 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
CN1479632A (zh) * 2000-10-09 2004-03-03 用于将核酸导入细胞的复合物
DE10145134A1 (de) * 2000-10-09 2002-05-16 Bayer Ag Komplexe zur Einführung von Nukleinsäuren in Zellen
WO2003038103A1 (fr) * 2001-10-29 2003-05-08 Atso Raasmaja Methode de transfection genetique faisant appel a des combinaisons synergiques de lipides cationiques et de polymeres cationiques
US7824910B2 (en) 2001-11-29 2010-11-02 Nippon Shokubai Co., Ltd. Method of transducing a protein into cells
JP2005518470A (ja) * 2002-02-22 2005-06-23 インサート セラピューティクス インコーポレイテッド 炭水化物−修飾ポリマー組成物及びその使用法
US20040048260A1 (en) * 2002-09-10 2004-03-11 Fu-Hsiung Chang Transfection of nucleic acid
US20040138154A1 (en) 2003-01-13 2004-07-15 Lei Yu Solid surface for biomolecule delivery and high-throughput assay
US7153905B2 (en) * 2003-03-21 2006-12-26 The General Hospital Corporation Hyperbranched dendron and methods of synthesis and use thereof
JP2007043972A (ja) * 2005-08-10 2007-02-22 Tokyo Institute Of Technology アパタイト粒子及びその作製方法、遺伝子−アパタイト粒子複合体及びその作製方法、並びに遺伝子導入方法及び遺伝子導入用キット
US20080145893A1 (en) * 2006-09-17 2008-06-19 Excellegene Sa Method for producing a recombinant protein at high specific productivity, high batch yield and high volumetric yield by means of transient transfection
JP2010535264A (ja) * 2007-07-31 2010-11-18 ポリプラス トランスフェクション トランスフェクション目的の直鎖ポリエチレンイミン(pei)を製造するための方法及びその方法で得られた直鎖pei
FR2928373B1 (fr) * 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
WO2010125544A1 (fr) 2009-04-30 2010-11-04 Genetic Immunity Kft. Composition de nanomédicament immunogène, préparation et utilisations de cette composition
AU2010306940A1 (en) 2009-10-12 2012-06-07 Smith, Larry Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
WO2016092569A1 (fr) * 2014-12-10 2016-06-16 Council Of Scientific & Industrial Research Composition micellaire inverse discontinue en phase fd3m cubique pour la libération prolongée de médicaments thérapeutiques
JP6873418B2 (ja) * 2016-11-11 2021-05-19 国立大学法人北陸先端科学技術大学院大学 遺伝子導入された細胞の製造方法及びポリエチレンイミンの置換体ポリマー
US20190353565A1 (en) 2016-12-01 2019-11-21 Norbert Gretz Means and methods for visualization of tissue structures
CN112237633B (zh) * 2020-10-22 2023-06-27 林君玉 一种pei/on复合物及其制备方法和用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2182306A (en) * 1935-05-10 1939-12-05 Ig Farbenindustrie Ag Polymerization of ethylene imines
NL45673C (fr) * 1935-05-11
DE2530042C3 (de) * 1975-07-04 1982-04-22 Institut neftechimičeskogo sinteza imeni A.V. Topčieva Akademii Nauk SSSR, Moskva Verfahren zur Herstellung von linearem Polyäthylenimin
US4032480A (en) * 1975-07-11 1977-06-28 David Solomonovich Zhuk Method of producing linear polyethylenimine
GB2128625B (en) * 1982-10-07 1986-01-08 Inst Neftechimicheskogo Sintez Method for preparing branched polyethylenimine
US4599400A (en) * 1984-12-18 1986-07-08 The Dow Chemical Company Star/comb-branched polyamide
GB8621337D0 (en) * 1986-09-04 1986-10-15 Agricultural Genetics Co Non-radioactive nucleic acid hybridization probes
US5977307A (en) * 1989-09-07 1999-11-02 Alkermes, Inc. Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
US6036955A (en) 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
IL112920A (en) * 1994-03-07 2003-04-10 Dow Chemical Co Composition comprising a dendritic polymer complexed with at least one unit of biological response modifier and a process for the preparation thereof
FR2722506B1 (fr) * 1994-07-13 1996-08-14 Rhone Poulenc Rorer Sa Composition contenant des acides nucleiques, preparation et utilisations
CA2226299A1 (fr) * 1995-08-11 1997-02-27 Dendritech, Inc. Conjugues de polymeres hyper-ramifies en peigne
BR9610626A (pt) * 1995-09-18 1999-04-06 Delta Chem Corp Métodos e composições depolicloretos de alumínio e policlorossulfatos de alumínio
DE19605279A1 (de) 1996-02-13 1997-08-14 Hoechst Ag Zielzellspezifische Vektoren für die Einschleusung von Genen in Zellen, Arzneimittel enthaltend derartige Vektoren und deren Verwendung
US5962429A (en) * 1996-11-22 1999-10-05 University Of Iowa Complexes of adenovirus with cationic molecules
DE19649645A1 (de) 1996-11-29 1998-06-04 Hoechst Ag Mehrfach funktionelles Ligandensystem zur zielzellspezifischen Übertragung von Nukleotidsequenzen
US5830730A (en) * 1997-05-08 1998-11-03 The Regents Of The University Of California Enhanced adenovirus-assisted transfection composition and method

Also Published As

Publication number Publication date
ES2264180T3 (es) 2006-12-16
US8003734B2 (en) 2011-08-23
DE19743135A1 (de) 1999-04-01
CA2249058A1 (fr) 1999-03-30
CY1105109T1 (el) 2009-11-04
AU758239B2 (en) 2003-03-20
TR199801933A2 (xx) 1999-04-21
HUP9802157A3 (en) 2003-02-28
BR9803982A (pt) 2000-03-28
EP0905254A3 (fr) 2002-01-02
CZ310598A3 (cs) 1999-04-14
PL328910A1 (en) 1999-04-12
HUP9802157A2 (hu) 1999-06-28
AU8714898A (en) 1999-04-22
HU9802157D0 (en) 1998-12-28
US20030027784A1 (en) 2003-02-06
JPH11187874A (ja) 1999-07-13
ATE324397T1 (de) 2006-05-15
US20110306656A1 (en) 2011-12-15
PT905254E (pt) 2006-08-31
KR19990030290A (ko) 1999-04-26
AR015726A1 (es) 2001-05-16
DE59813507D1 (de) 2006-06-01
ID20973A (id) 1999-04-01
JP4399042B2 (ja) 2010-01-13
EP0905254A2 (fr) 1999-03-31
EP0905254B1 (fr) 2006-04-26

Similar Documents

Publication Publication Date Title
DK0905254T3 (da) Fremgangsmåde til fremstilling af en lavemolekylær
DK1032566T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0790226T3 (da) Fremgangsmåde til fremstilling af methanol
NO980288D0 (no) Gassfasepolymerisasjonsprosess
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DE69832369D1 (de) Hämofiltrationssystem
DK0906784T4 (da) Fremgangsmåde til fremstilling af bundne zeolitter
DK1005517T3 (da) Fremgangsmåde til fremstilling af diglycerider
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
ATE291038T1 (de) Polymerisationsverfahren
DK0996642T3 (da) Fremgangsmåde til fremstilling af heparin
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0970939T3 (da) Fremgangsmåde til fremstilling af methanol
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
ATE386058T1 (de) Polymerisationsverfahren
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0952137T3 (da) Fremgangsmåde til fremstilling af 2,3,5-trimethylhydroquinondiestere
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK0855379T3 (da) Fremgangsmåde til fremstilling af benzophenonderivater